NCT01958229
- Conditions
- 24-week PCR Negativity of Telbivudine, Blood-Borne Infections, Chronic Disease, +19 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Clinical trial condition
Explore clinical trials studying Roadmap Concept in Chronic Hepatitis B Treatment. Study availability and eligibility vary by location and protocol.
NCT01958229